WeSearch

Why Israel’s lawsuit against Times over ‘blood libel’ has a chance

·7 min read · 0 reactions · 0 comments · 44 views
Why Israel’s lawsuit against Times over ‘blood libel’ has a chance
TL;DR · WeSearch summary

Israel is suing the New York Times and columnist Nicholas Kristof for defamation over a column alleging sexual abuse of Palestinians. Prime Minister Benjamin Netanyahu described the column as a 'blood libel' and criticized it for being published before an independent report on Hamas's actions. The lawsuit could challenge the Times' journalistic practices and alleged bias against Israel.

Key facts
About this source

New York Post files mainly under news. We currently carry 11,003 of its stories.

Original article
New York Post
Read full at New York Post →

Story provenance

Source · retrieval · rights · ranking — open for full record
inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisherNew York Post
Canonical URLhttps://nypost.com/2026/05/17/opinion/why-israels-lawsuit-against-times-over-blood-libel-has-a-chance/
Publication timeSun, 17 May 2026 14:02:40 -0400
Retrieval time2026-05-17T18:03:33.909Z
Last seen2026-05-17T18:03:33.909Z
Headline sourcePublisher (no WeSearch rewrite)
Excerpt sourcepublisher body
Excerpt methodFirst ~120 words (~800 chars) of extracted publisher body, fair-use limited.
SummaryWeSearch · cerebras-chat (WeSearch summarizer)
Summary source textcontentText
Citation coverageSummary is a WeSearch-generated derivative; primary citation is the original publisher URL.
ClusterKH8E2eRixYoI
Cluster logicGrouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reasonStory pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visitYes — open original
Substitutes article?No — link-out required for full text

Rights status (four layers)

Publisher-declared
No publisher-confirmed rights record for this source yet.
Machine-readable
No source-specific machine-readable restriction detected beyond the public feed.
WeSearch interpretation
WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.
Unknown
Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing May the item be indexed (stored, ranked, made findable)? Allowed
Snippet May a short excerpt of the publisher's text be shown? Allowed
AI summary May WeSearch generate its own short summary of the article? Limited
Retrieval / RAG May the content be exposed for third-party retrieval-augmented generation? Not asserted
Model training May the content be used to train AI models? Not asserted
Commercial reuse May the content be reused commercially? Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Opening excerpt (first ~120 words) tap to expand

Opinion Why Israel’s lawsuit against Times over ‘blood libel’ has a chance By Jonathan Turley Published May 17, 2026, 2:02 p.m. ET The Red Cross convoy carrying Palestinian prisoners released in the second round of the prisoner swap between Hamas and Israel reach the town of Beitunya in Ramallah, West Bank on January 25, 2025. Anadolu via Getty Images Does the “Gray Lady” have a “longstanding Jewish problem“? That question may soon be answered in a Manhattan courtroom as the New York Times stands accused of an alleged attack piece on Israel.

Excerpt limited to ~120 words for fair-use compliance. The full article is at New York Post.

Anonymous · no account needed
Share 𝕏 Facebook Reddit LinkedIn Threads WhatsApp Bluesky Mastodon Email

Discussion

0 comments

More from New York Post